NCT00489593 Olanzapine in Patients With Advanced Cancer and Weight Loss Status COMPLETED Phase PHASE1
NCT00485771 Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression Status COMPLETED Phase PHASE4
NCT00483964 A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia Status COMPLETED Phase PHASE2
NCT00438776 Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling Status COMPLETED Phase PHASE3
NCT00433121 Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD Status COMPLETED Phase PHASE4
NCT00423878 Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00419653 Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy Status TERMINATED Phase PHASE4
NCT00418171 Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac) Status COMPLETED Phase PHASE4
NCT00402324 A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients Status COMPLETED Phase PHASE4
NCT00401973 Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine Status COMPLETED Phase PHASE3
NCT00396565 A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00391222 A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00363376 A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain Status COMPLETED Phase PHASE3
NCT00347425 Switch Study of Existing Atypical Antipsychotics to Bifeprunox Status COMPLETED Phase PHASE3
NCT00337662 Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia Status COMPLETED Phase PHASE4
NCT00330863 Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy Status COMPLETED Phase PHASE4
NCT00320489 Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00290121 Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics Status COMPLETED Phase PHASE4